MedTrace Logo

Multicenter Cross Sectional Study of Primary Intestine Lymphoma

NCT01043302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 545

Last updated 2010-07-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether whether surgical resection followed by chemotherapy is superior to systemic chemotherapy alone in terms of treatment outcome and quality of life (QOL) in patients with primary intestinal lymphoma.

Conditions

  • Non-Hodgkin Lymphoma of Intestine

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Seok Jin Kim, MD.,PhD · Samsung Medical Center

Eligibility

Min Age
15 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01043302 on ClinicalTrials.gov